{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T15:12:59Z","timestamp":1794755579170,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["EVD-184698"],"award-info":[{"award-number":["EVD-184698"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Canada\u2019s historical reliance on criminal justice approaches to drug policy has intensified structural and social stigma, and high-risk behaviours among people who use drugs. In response to pressure from local advocates, British Columbia implemented a pilot decriminalization policy in January 2023, permitting adults to possess up to 2.5\u00a0g of specified unregulated substances, cumulatively. While not designed to address the toxic drug supply directly, it aimed to reduce stigma and encourage engagement with health and harm reduction services. In May 2024, however, drug possession in public spaces was recriminalized, raising concerns about a return to punitive environments. To date, little is known about how these policy shifts have been experienced by people who use drugs themselves. We conducted a qualitative study exploring the impacts of British Columbia\u2019s decriminalization policy and its subsequent recriminalization amendment on the drug use behaviours of people who use drugs across the province.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A cross-sectional qualitative study with 75 people who use drugs across British Columbia, including a socio-demographic survey, and semi-structured interviews. Interviews were transcribed verbatim and analyzed using thematic analysis. The codebook was applied across all transcripts using a comparative approach to identify recurring patterns, divergent experiences, and key themes related to drug use behaviours.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Participants reported little to no change in their drug use patterns following either decriminalization or recriminalization, as drug use was primarily driven by dependence, routine, and structural factors. Nonetheless, many described a psychological benefit under decriminalization, including reduced shame, internalized stigma, and fear of criminalization. These gains were largely reversed following the recriminalization amendment, which pushed drug use back into hidden, high-risk environments. Participants also noted destabilizing shifts in the drug supply, including increased potency and a rise in less experienced dealers, linked to the 2.5\u00a0g threshold.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Decriminalization did not significantly alter drug use behaviours but offered notable psychological relief for participants. The subsequent recriminalization amendment then reversed these perceived gains, illustrating how this abrupt policy change led to unintended consequences, undermining the original goals of the decriminalization policy. These findings highlight the need for sustained and structurally supported effective policy approaches that center the lived realities of people who use drugs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12954-025-01322-9","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T13:17:14Z","timestamp":1760447834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Stable patterns, shifting risks: the impact of British Columbia\u2019s decriminalization and recriminalization policies on drug use behaviours"],"prefix":"10.1186","volume":"22","author":[{"given":"Farihah","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Mende-Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cayley","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savannah","family":"Torres-Salbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff","family":"Bardwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Bonn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juls","family":"Budau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ivsins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"1322_CR1","unstructured":"Government of Canada. Opioid- and Stimulant-related Harms in Canada Ottawa, ON: Public Health Agency of Canada; 2025 [updated June 25, 2025. Available from: https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants\/."},{"key":"1322_CR2","unstructured":"Canadian Drug Policy Coalition. History of Drug Policy in Canada [Available from: https:\/\/drugpolicy.ca\/about\/history\/."},{"issue":"8","key":"1322_CR3","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/amajethics.2020.723","volume":"22","author":"M Tyndall","year":"2020","unstructured":"Tyndall M, Dodd Z. How structural violence, prohibition, and stigma have paralyzed North American responses to opioid overdose. AMA J Ethics. 2020;22(8):723\u20138.","journal-title":"AMA J Ethics"},{"key":"1322_CR4","unstructured":"Public Safety Canada. Homelessness, Victimization and Crime: Knowledge and Actionable Recommendations. Ottawa, ON: University of Ottawa, Institute for the Prevention of Crime; 2008. Report No.: 978-0-9784538-2-4"},{"key":"1322_CR5","unstructured":"Toronto Public Health. Quick Facts: Harms Associated with Drug Laws. 2018."},{"key":"1322_CR6","unstructured":"Association APH. Defining and implementing a public health response to drug use and misuse. 2013. 2018."},{"key":"1322_CR7","unstructured":"CATIE. How do social and structural factors increase risk of wounds and bacterial infections for people who inject drugs?. 2024."},{"key":"1322_CR8","unstructured":"Government of British Columbia. Decriminalizing people who use drugs in B.C. 2025 [updated June 26, 2025. Available from: https:\/\/www2.gov.bc.ca\/gov\/content\/overdose\/decriminalization."},{"key":"1322_CR9","doi-asserted-by":"publisher","first-page":"103933","DOI":"10.1016\/j.drugpo.2022.103933","volume":"111","author":"C Russell","year":"2023","unstructured":"Russell C, Law J, Bonn M, Rehm J, Ali F. The increase in benzodiazepine-laced drugs and related risks in Canada: the urgent need for effective and sustainable solutions. Int J Drug Policy. 2023;111:103933.","journal-title":"Int J Drug Policy"},{"key":"1322_CR10","unstructured":"BC Centre for Disease Control. Decriminalization in B.C. 2025 [Available from: http:\/\/www.bccdc.ca\/health-info\/prevention-public-health\/decriminalization-in-bc."},{"key":"1322_CR11","doi-asserted-by":"publisher","first-page":"100010","DOI":"10.1016\/j.ssmqr.2021.100010","volume":"1","author":"HT Saleem","year":"2021","unstructured":"Saleem HT, Zhang L, Silberg C, Latkin C, Likindikoki S. Structural, everyday, and symbolic violence and the heightened vulnerability to HIV of women who use drugs in Tanzania. SSM Qual Res Health. 2021;1:100010.","journal-title":"SSM Qual Res Health"},{"issue":"1","key":"1322_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12954-024-01108-5","volume":"21","author":"F Ali","year":"2024","unstructured":"Ali F, Russell C, Lo M, Bonn M, Bardwell G, Boyd J, et al. Unpacking the effects of decriminalization: understanding drug use experiences and risks among individuals who use drugs in British Columbia. Harm Reduct J. 2024;21(1):190.","journal-title":"Harm Reduct J"},{"key":"1322_CR13","unstructured":"Wood B, Zakimi N, Greer A. Drug decriminalization in British Columbia: a qualitative study with people who use drugs. Phase 2 research report. 2024."},{"key":"1322_CR14","doi-asserted-by":"publisher","first-page":"104126","DOI":"10.1016\/j.drugpo.2023.104126","volume":"119","author":"E McAdam","year":"2023","unstructured":"McAdam E, Small W, Mullins G, Graham B, Greer A, Winder N, et al. Decriminalization thresholds for drug possession: a multi-criteria policy analysis framework. Int J Drug Policy. 2023;119:104126.","journal-title":"Int J Drug Policy"},{"key":"1322_CR15","doi-asserted-by":"publisher","first-page":"104478","DOI":"10.1016\/j.drugpo.2024.104478","volume":"129","author":"L Michaud","year":"2024","unstructured":"Michaud L, McDermid J, Bailey A, Kelsall TS. Decriminalization or police mission creep? Critical appraisal of law enforcement involvement in British Columbia, Canada\u2019s decriminalization framework. Int J Drug Policy. 2024;129:104478.","journal-title":"Int J Drug Policy"},{"key":"1322_CR16","unstructured":"Government of British Columbia. B.C. moves to ban drug use in public spaces, taking more steps to keep people safe. Office of the Premier. 2024."},{"key":"1322_CR17","doi-asserted-by":"publisher","DOI":"10.17269\/s41997-025-01012-w","author":"KA Speed","year":"2025","unstructured":"Speed KA, Gallant K, Fleury M, McAdam E, Kelsall TS. Decriminalization undone: assessing the amendment to British Columbia\u2019s decriminalization of personal drug possession framework. Can J Public Health. 2025. https:\/\/doi.org\/10.17269\/s41997-025-01012-w.","journal-title":"Can J Public Health"},{"key":"1322_CR18","unstructured":"First Nations Health Authority. Two years into decriminalization legislation in British Columbia 2025 [Available from: https:\/\/www.fnha.ca\/about\/news-and-events\/news\/two-years-into-decriminalization-legislation-in-british-columbia."},{"issue":"5","key":"1322_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","volume":"42","author":"LA Palinkas","year":"2015","unstructured":"Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42(5):533\u201344.","journal-title":"Adm Policy Ment Health"},{"issue":"3","key":"1322_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5812\/sdme.67670","volume":"14","author":"M Naderifar","year":"2017","unstructured":"Naderifar M, Goli H, Ghaljaie F. Snowball sampling: a purposeful method of sampling in qualitative research. Strides Dev Med Educ. 2017;14(3):1\u20136.","journal-title":"Strides Dev Med Educ"},{"key":"1322_CR21","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"key":"1322_CR22","unstructured":"Government of Canada. Community Health Service Areas Boundaries. 2020."},{"issue":"10","key":"1322_CR23","first-page":"2552","volume":"23","author":"D Deggs","year":"2018","unstructured":"Deggs D, Hernandez F. Enhancing the value of qualitative field notes through purposeful reflection. The Qualitative Report. 2018;23(10):2552\u201360.","journal-title":"The Qualitative Report"},{"key":"1322_CR24","first-page":"1947","volume-title":"Thematic analysis","author":"V Clarke","year":"2014","unstructured":"Clarke V, Braun V. Thematic analysis. Encyclopedia of critical psychology: Springer; 2014. p. 1947\u201352."},{"issue":"2","key":"1322_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/2159676X.2019.1704846","volume":"13","author":"V Braun","year":"2021","unstructured":"Braun V, Clarke V. To saturate or not to saturate? Questioning data saturation as a useful concept for thematic analysis and sample-size rationales. Qual Res Sport Exerc Health. 2021;13(2):201\u201316.","journal-title":"Qual Res Sport Exerc Health"},{"issue":"1","key":"1322_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/hex.13384","volume":"25","author":"B Allemang","year":"2022","unstructured":"Allemang B, Sitter K, Dimitropoulos G. Pragmatism as a paradigm for patient-oriented research. Health Expect. 2022;25(1):38\u201347.","journal-title":"Health Expect"},{"key":"1322_CR27","unstructured":"Drug Policy Alliance. Approaches to Decriminalizing Drug Use & Possession 2015."},{"key":"1322_CR28","doi-asserted-by":"publisher","first-page":"103999","DOI":"10.1016\/j.drugpo.2023.103999","volume":"114","author":"AL Sibley","year":"2023","unstructured":"Sibley AL, Baker R, Levander XA, Rains A, Walters SM, Nolte K, et al. \u201cI am not a junkie\u201d: Social categorization and differentiation among people who use drugs. Int J Drug Policy. 2023;114:103999.","journal-title":"Int J Drug Policy"},{"key":"1322_CR29","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.drugpo.2018.03.032","volume":"56","author":"I Benfer","year":"2018","unstructured":"Benfer I, Zahnow R, Barratt MJ, Maier L, Winstock A, Ferris J. The impact of drug policy liberalisation on willingness to seek help for problem drug use: a comparison of 20 countries. Int J Drug Policy. 2018;56:162\u201375.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1322_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13011-021-00394-7","volume":"16","author":"X R\u00eago","year":"2021","unstructured":"R\u00eago X, Oliveira MJ, Lameira C, Cruz OS. 20 years of Portuguese drug policy-developments, challenges and the quest for human rights. Subst Abuse Treat Prev Policy. 2021;16(1):59.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"1322_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1139\/facets-2022-0080","volume":"9","author":"V Gruben","year":"2024","unstructured":"Gruben V, Hyshka E, Bonn M, Cox C, Gagnon M, Guta A, et al. Urgent and long overdue: legal reform and drug decriminalization in Canada. Facets. 2024;9:1\u201328.","journal-title":"Facets"},{"issue":"3","key":"1322_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1177\/00914509231179226","volume":"50","author":"BD Scher","year":"2023","unstructured":"Scher BD, Neufeld SD, Butler A, Bonn M, Zakimi N, Farrell J, et al. \u201cCriminalization causes the stigma\u201d: perspectives from people who use drugs. Contemp Drug Probl. 2023;50(3):402\u201325.","journal-title":"Contemp Drug Probl"},{"issue":"2","key":"1322_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/pch\/pxad006","volume":"29","author":"A Holland","year":"2024","unstructured":"Holland A, Etches S, Gander S. Drug decriminalization: the importance of policy change for the health and wellbeing of children and youth in Canada. Paediatr Child Health. 2024;29(2):87\u20139.","journal-title":"Paediatr Child Health"},{"key":"1322_CR34","unstructured":"Canadian Psychological Association. The Decriminalization of Illegal Substances in Canada. 2023."},{"issue":"1","key":"1322_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13011-023-00547-w","volume":"18","author":"F Ali","year":"2023","unstructured":"Ali F, Russell C, Greer A, Bonn M, Werb D, Rehm J. \u201c2.5 g, I could do that before noon\u201d: a qualitative study on people who use drugs\u2019 perspectives on the impacts of British Columbia\u2019s decriminalization of illegal drugs threshold limit. Subst Abuse Treat Prev Policy. 2023;18(1):32.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"1322_CR36","unstructured":"Canadian Drug Policy Coalation. B.C.\u2019s Decriminalization Pilot and VPD Drug Seizures 2024 [Available from: https:\/\/drugpolicy.ca\/b-c-s-decriminalization-pilot-and-vpd-drug-seizures\/."},{"issue":"1","key":"1322_CR37","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12954-022-00725-2","volume":"19","author":"G Bardwell","year":"2022","unstructured":"Bardwell G, Mansoor M, Van Zwietering A, Cleveland E, Snell D, Kerr T. The, \u201cgoldfish bowl\u201d: a qualitative study of the effects of heightened surveillance on people who use drugs in a rural and coastal Canadian setting. Harm Reduct J. 2022;19(1):136.","journal-title":"Harm Reduct J"},{"key":"1322_CR38","doi-asserted-by":"publisher","first-page":"102695","DOI":"10.1016\/j.drugpo.2020.102695","volume":"78","author":"JJ Carroll","year":"2020","unstructured":"Carroll JJ, Rich JD, Green TC. The protective effect of trusted dealers against opioid overdose in the US. Int J Drug Policy. 2020;78:102695.","journal-title":"Int J Drug Policy"},{"key":"1322_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2019.01.035","volume":"198","author":"G Bardwell","year":"2019","unstructured":"Bardwell G, Boyd J, Arredondo J, McNeil R, Kerr T. Trusting the source: the potential role of drug dealers in reducing drug-related harms via drug checking. Drug Alcohol Depend. 2019;198:1\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"1322_CR40","unstructured":"Interior Health. Mixed Opioid and Benzodiazepine Overdose: Learn How to Respond. 2021."},{"key":"1322_CR41","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.drugpo.2017.05.050","volume":"46","author":"L Beletsky","year":"2017","unstructured":"Beletsky L, Davis CS. Today\u2019s fentanyl crisis: prohibition\u2019s iron law, revisited. Int J Drug Policy. 2017;46:156\u20139.","journal-title":"Int J Drug Policy"},{"key":"1322_CR42","unstructured":"Canadian Drug Policy Coalation. Case for Reform [Available from: https:\/\/drugpolicy.ca\/our-work\/case-for-reform\/."},{"key":"1322_CR43","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","volume":"71","author":"D Ciccarone","year":"2019","unstructured":"Ciccarone D. The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019;71:183\u20138.","journal-title":"Int J Drug Policy"},{"key":"1322_CR44","unstructured":"Ontario Drug Policy Research Network. Accidental drug and alcohol-related deaths rising in Ontario, especially those involving multiple substances: report. Public Health Ontario. 2025."},{"key":"1322_CR45","unstructured":"Government of Canada. Canada\u2019s overdose crisis and the toxic illegal drug supply 2024 [Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/opioids\/overdose-crisis-toxic-illegal-drug-supply.html."},{"key":"1322_CR46","unstructured":"National Harm Reduction Coalition. Opioid Overdose Basics: Overdose Risks & Prevention [Available from: https:\/\/harmreduction.org\/issues\/overdose-prevention\/overview\/overdose-basics\/opioid-od-risks-prevention\/#:~:text=While%20using%20alone%20isn't,you%20if%20you%20go%20out."},{"issue":"6","key":"1322_CR47","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1001\/jamapsychiatry.2023.0596","volume":"80","author":"M Olfson","year":"2023","unstructured":"Olfson M, Cosgrove CM, Wall MM, Blanco C. Living alone and drug overdose deaths in the US. JAMA Psychiatr. 2023;80(6):645\u20137.","journal-title":"JAMA Psychiatr"},{"issue":"3","key":"1322_CR48","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1080\/10826084.2023.2280534","volume":"59","author":"VS Deo","year":"2024","unstructured":"Deo VS, Bhullar MK, Gilson TP, Flannery DJ, Fulton SE. The need to rethink harm reduction for people using drugs alone to reduce overdose fatalities. Subst Use Misuse. 2024;59(3):450\u20138.","journal-title":"Subst Use Misuse"},{"issue":"2","key":"1322_CR49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.drugpo.2005.12.005","volume":"17","author":"W Small","year":"2006","unstructured":"Small W, Kerr T, Charette J, Schechter MT, Spittal PM. Impacts of intensified police activity on injection drug users: evidence from an ethnographic investigation. Int J Drug Policy. 2006;17(2):85\u201395.","journal-title":"Int J Drug Policy"},{"key":"1322_CR50","doi-asserted-by":"publisher","first-page":"103491","DOI":"10.1016\/j.drugpo.2021.103491","volume":"100","author":"W Pedersen","year":"2022","unstructured":"Pedersen W, Moffitt TE, von Soest T. Privileged background protects against drug charges: a long-term population-based longitudinal study. Int J Drug Policy. 2022;100:103491.","journal-title":"Int J Drug Policy"},{"key":"1322_CR51","doi-asserted-by":"publisher","first-page":"104688","DOI":"10.1016\/j.drugpo.2024.104688","volume":"136","author":"TS Kelsall","year":"2025","unstructured":"Kelsall TS, Veark J, Beatrice M. Criminalizing public space through a decriminalization framework: the paradox of British Columbia, Canada. Int J Drug Policy. 2025;136:104688.","journal-title":"Int J Drug Policy"},{"key":"1322_CR52","unstructured":"On Canada Project. Why We Need To Decriminalize Drugs In Canada [Available from: https:\/\/oncanadaproject.ca\/blog\/why-we-need-to-decriminalize-drugs-in-canada."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01322-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01322-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01322-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T13:17:29Z","timestamp":1760447849000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01322-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1322"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01322-9","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received research ethics approval from the Centre for Addiction and Mental Health (CAMH) (REB #2023\/088). All participants provided informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}